Prestige Biologics Site Tour
Concept
Prestige Biologics was established in 2015 and completed its first plant in the Chungbuk Osong Life Science Complex in 2018. The four plants have a total manufacturing capacity of 154,000 liters. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 features the Hybrid ALITA Smart BioFactory™, which combines the advantages of single-use systems and stainless steel, delivering exceptional performance.
The facility received GMP certification from the Ministry of Food and Drug Safety (MFDS) in Korea and the European Union (EU) in 2019 and 2021, respectively. U.S. FDA inspections for both campuses are expected in 2025.
Prestige Biologics offers a One-Stop Solution, catering to customer needs throughout the entire biopharmaceutical production process, from manufacturing process development and clinical sample production to step-by-step regulatory support and commercial production.
Register your interest now and join us for this exclusive site tour to experience firsthand how Prestige Biologics has leveraged innovation to elevate its manufacturing capabilities!
Highlights
- Gain valuable insights and explore practical applications through scientific talks.
- Explore cutting-edge solutions at our product demonstrations and exhibition.
- Connect & engage with industry experts and peers to discuss innovative strategies for utilizing Sartorius' solutions.
Sessions
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.